Slow-releasing implants are designed to reduce side effects associated with medications for pain relief of rheumatoid arthritis and osteoarthritis
For rheumatologic conditions like rheumatoid arthritis and osteoarthritis, NSAIDS are often the first line of medications used for pain relief. UConn Pharmacy researchers have discovered a way to minimize the side effects associated with the treatment and bring it to market.
Nonsteroidal anti-inflammatory drugs (NSAIDS) are widely used to relieve pain, reduce fever, and bring down inflammation. More than 30 billion doses are taken each year — making them among the most popular medications worldwide for general pain relief… Continue reading.
Three cross-disciplinary teams of UConn researchers from the Storrs campus and the Health Center in Farmington recently received two-year start-up grants of $100,000 from the University to pursue their work. The funding through the University of Connecticut Health Center/Storrs and Regional Campus Incentive Grants (UCIG) program, are meant to support interdisciplinary, inter-campus research proposals that show long-term promise, and are likely to attract additional outside funding once the University’s seed money expires…
…A second team of UConn researchers is developing a new nanomedicine approach to target therapy-resistant cancer stem cells. Recent advances in science have led to a better understanding of the characteristics of therapy-resistant cancer stem cells. The UConn research team hopes to use this new information to build a foundation for novel, reliable nanomedicine therapies.
The research team working on the project consists of Diane Burgess, UConn Board of Trustees Distinguished Professor of Pharmacy; Bryan Huey, associate professor in chemical, materials, and biomolecular engineering; and Liisa Kuhn, assistant professor of reconstructive sciences at the UConn Health Center.
A team of researchers in chemistry, pharmaceutics, and engineering is developing a long term implantable biosensor that could dramatically change the way of life for millions of people diagnosed with diabetes.
Inside the laboratories of Board of Trustees distinguished professor of pharmaceutics Diane Burgess, chemistry professor Fotios Papadimitrakopoulos, and engineering professor Faquir Jain, teams of graduate students and postdoctoral fellows are helping develop a miniaturized wireless device that will monitor blood glucose levels for three months or more after being inserted under a patient’s skin.